FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Vaccine | Novartis | MenB | meningitis

Novartis' MenB vaccine protects infants

Tools
  • Email
  • Print
  • Comment
  • Contact Author
  • Reprint

A fresh batch of trial data indicates that the Novartis Meningitis B vaccine protects infants six months and older against multiple strains of potentially deadly meningococcal B bacteria. More than 95 percent of the infants in the study aged six to 12 months demonstrated an immune response against strains representing multiple antigens. Meningococcal B strains accounted for 72 percent of meningococcal disease in Europe in 2006.

"These are encouraging new findings that indicate the Novartis MenB vaccine may also offer infants six months and older robust protection against multiple strains of meningococcal B bacteria," said Matthew Snape, MD, MBBS, FRCPCH, Consultant in Vaccinology, Oxford Vaccine Group, University of Oxford; Honorary Consultant Paediatrician, John Radcliffe Hospital, Oxford. "Providing broad protection against meningococcal B disease is a global health priority."

- read Novartis' release

Related Articles:
Novartis reports strong meningitis vaccine response
Novartis meningitis vaccine delivers positive data
Novartis pays big for roster of new vaccines

More stories about Vaccine   Novartis   MenB   meningitis  

Comments

The Meningitis Foundation of America (MFA), a national organization, would like the public and media to know that information is available regarding the diagnosis, treatment and prevention of meningitis. MFA was founded by parents whose children were affected by meningitis. In addition to supporting vaccines and other means of preventing meningitis, the MFA provides information to educate the public and medical professionals so that the early diagnosis, treatment and, most important, prevention of meningitis, will save lives. Meningitis is a dangerous and sometimes fatal inflammation of the brain and/or spinal cord that can leave survivors with serious life-long physical problems such as deafness, brain damage and other disabilities, meningitis can sometimes result in loss of limbs. MFA would like to be considered as a news resource for the disease. For further information, visit the MFA website at www.musa.org.

MFA is proud to announce the new C.I.S.S. Container Identification Scratch System
When we participate in sporting events or mingle at social gatherings it is possible to lose track of our water bottles and/or beverage cans, especially those served in containers that are very similar or identical to a container from which you are drinking. This carries the risk of transmitting an illness, such as meningitis or the common cold or flu. The Container Identification Scratch System, or C.I.S.S., is a fun way to make sure you always know your drink from others. Use it at sporting events or at a family gatherings and reduce the waste from forgotten drinks. Simply scratch your number from the C.I.S.S. label and identify your drink. For more information please contact Bob Gold at Ciss.bob@gmail.com and www.musa.org

Thank you,

Ms. Jamie Callahan, General Manager
Meningitis Foundation of America
212 W 10th Street, Suite B-330
Indianapolis, IN 46202
(800) 668-1129
www.musa.org

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 84 + 10?
To combat spam, please solve the math question above.